Pliant Therapeutics, Inc. (Nasdaq: PLRX), a late-stage biotechnology company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases, today announced ...
'We are pleased to welcome Chris as we enter the next phase of our growth,' said Alignable CEO & Co-Founder Eric Groves. 'His expertise in scaling companies and his strategic vision will be invaluable ...
Broadcast intercom systems play a crucial role in coordinating complex productions and ensuring clear communication ... Read ...